NM_001267550.2(TTN):c.32026A>G (p.Lys10676Glu) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Nov 9, 2017
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000643729.5

Allele description [Variation Report for NM_001267550.2(TTN):c.32026A>G (p.Lys10676Glu)]

NM_001267550.2(TTN):c.32026A>G (p.Lys10676Glu)

Gene:

TTN:titin [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q31.2

Genomic location:

Preferred name:

NM_001267550.2(TTN):c.32026A>G (p.Lys10676Glu)

Other names:

p.K9432E:AAG>GAG

HGVS:

NC_000002.12:g.178689122T>C
NG_011618.3:g.146681A>G
NM_001256850.1:c.31075A>G
NM_001267550.2:c.32026A>GMANE SELECT
NM_003319.4:c.13283-46805A>G
NM_133378.4:c.28294A>G
NM_133432.3:c.13658-46805A>G
NM_133437.4:c.13859-46805A>G
NP_001243779.1:p.Lys10359Glu
NP_001254479.2:p.Lys10676Glu
NP_596869.4:p.Lys9432Glu
LRG_391:g.146681A>G
NC_000002.11:g.179553849T>C
NM_001256850.1:c.31075A>G
NM_001267550.1:c.32026A>G

Protein change:

K10359E

Links:

dbSNP: rs200952728

NCBI 1000 Genomes Browser:

rs200952728

Molecular consequence:

NM_003319.4:c.13283-46805A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_133432.3:c.13658-46805A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_133437.4:c.13859-46805A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001256850.1:c.31075A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001267550.2:c.32026A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_133378.4:c.28294A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Dilated cardiomyopathy 1G (CMD1G)
Identifiers:: MONDO: MONDO:0011400; MedGen: C1858763; Orphanet: 154; OMIM: 604145

Name:: Autosomal recessive limb-girdle muscular dystrophy type 2J (LGMDR10)
Synonyms:: Limb-girdle muscular dystrophy, type 2J; MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10
Identifiers:: MONDO: MONDO:0012127; MedGen: C1837342; Orphanet: 140922; OMIM: 608807

Recent activity

Clear Turn Off Turn On

Pf-06281355 (0)
Books
hypothetical protein FOXG_00902 [Fusarium oxysporum f. sp. lycopersici 4287]
hypothetical protein FOXG_00902 [Fusarium oxysporum f. sp. lycopersici 4287]
gi|1070315539|ref|XP_018233292.1|

Protein
cytochrome c oxidase subunit I, partial (mitochondrion) [Madracis pharensis]
cytochrome c oxidase subunit I, partial (mitochondrion) [Madracis pharensis]
gi|1704618205|gb|QDM02512.1|

Protein
NADH dehydrogenase subunit 1, partial (mitochondrion) [Madracis pharensis]
NADH dehydrogenase subunit 1, partial (mitochondrion) [Madracis pharensis]
gi|312234474|gb|ADQ54243.1|

Protein
Rhizobiaceae recombinase A (recA) gene, partial cds.
Rhizobiaceae recombinase A (recA) gene, partial cds.
PopSet: 630367489

PopSet

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000765416	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Nov 9, 2017)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000765416

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Nov 9, 2017)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000765416.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine